Nicholas Investment Partners, LP Collegium Pharmaceutical, Inc Transaction History

Nicholas Investment Partners, LP

  • $845 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$14.16 - $24.3 $2.97 Million - $5.09 Million
-209,447 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$21.79 - $28.29 $414,271 - $537,849
19,012 Added 9.98%
209,447 $5 Million
Q1 2018

May 15, 2018
SELL
$18.15 - $29.21 $102,692 - $165,270
-5,658 Reduced 2.89%
190,435 $4.87 Million
Q4 2017

Feb 14, 2018
BUY
$9.3 - $19.14 $1.82 Million - $3.75 Million
196,093
196,093 $3.62 Million

Others Institutions Holding COLL

# of Institutions
239
Shares Held
39.8M
Call Options Held
84.2K
Put Options Held
18.6K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.17B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email